Author:
Cortelezzi A,Pasquini M C,Gardellini A,Gianelli U,Bossi A,Reda G,Sarina B,Musto P,Barcellini W,Neri A,Deliliers G L
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference25 articles.
1. Keating MJ, Flinn I, Jain V, Binet JL, Hillmen P, Byrd J et al. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood 2002; 99: 3554–3561.
2. Moreno C, Montserrat E . New prognostic markers in chronic lymphocytic leukemia. Blood Rev 2008; 22: 211–219.
3. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916.
4. Faderl S, O'Brien S, Keating MJ . Monoclonal antibody combinations in CLL: evolving strategies. Best Pract Res Clin Haematol 2007; 20: 781–793.
5. Christian BA, Lin TS . Antibody therapy for chronic lymphocytic leukemia. Semin Hematol 2008; 45: 95–103.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献